ARID1A and intrahepatic cholangiocarcinoma: Low ARID1A expression was significantly associated with worse OS (HR = 3.97, 95% CI: 1.299–12.118, P = 0.016) in ICC; ARID1A was also associated with tumor nodules, vein invasion, and tumor recurrence status